{{medical}}
{{Infobox drug
| IUPAC_name        = ''N'',''N''-Dimethylimidodicarbonimidic diamide
| image             = Metformin.svg
| alt               = 
| image2            = Metformin-from-xtal-3D-balls.png
| alt2              = 
| caption           =
<!--Clinical data -->
| pronounce   = {{IPAc-en|m|ɛ|t|ˈ|f|ɔr|m|ɨ|n}}, {{respell|met|FAWR|min}}
| tradename         = Glucophage, other
| Drugs.com         = {{drugs.com|monograph|metformin-hydrochloride}}
| MedlinePlus       = a696005
| licence_EU        = <!-- EMA requires brand name -->
| licence_US        = metformin
| DailyMedID        = <!-- preference to licence_US -->
| pregnancy_AU      = C
| pregnancy_US      = B
| pregnancy_category= 
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| legal_status      = 
| dependency_liability = 
| routes_of_administration = 口服

<!--Pharmacokinetic data -->
| bioavailability   = 50–60%<ref name = D95>{{cite journal |vauthors=Dunn CJ, Peters DH | title = Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus | journal = Drugs | volume = 49 | issue = 5 | pages = 721–49 |date=May 1995  | pmid = 7601013 | doi = 10.2165/00003495-199549050-00007 }}</ref><ref name=D03>{{cite journal |vauthors=Hundal RS, Inzucchi SE | title = Metformin: new understandings, new uses | journal = Drugs | volume = 63 | issue = 18 | pages = 1879–94 | year = 2003 | pmid = 12930161 | doi = 10.2165/00003495-200363180-00001 }}</ref>
| protein_bound     = 很小<ref name = D95/>
| metabolism        = 不经过肝脏<ref name = D95/>
| elimination_half-life = 4-8.7小时<ref name = D95/>
| excretion         = 尿液（90%）<ref name = D95/>

<!--Identifiers -->
| index0 = 
| index2 = hydrochloride
| CAS_number        = 657-24-9
| CAS_number_Ref = {{cascite|correct}}
| CAS_supplemental  = 
| IUPHAR_ligand = 4779
| synonyms          = 
| PubChem = 4091
| ChemSpiderID = 3949
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| UNII = 9100L32L2N
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII2 = 786Z46389E
| DrugBank = DB00331
| KEGG = D04966
| KEGG_Ref = {{keggcite|correct|kegg}}
| ChEBI = 6801
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1431
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ATC_prefix = A10
| ATC_suffix = BA02

<!--Chemical data -->
| chemical_formula  =
| C=4 | H=11 | N=5
| molecular_weight  = 129.16364 g/mol
| smiles            = CN(C)C(=N)NC(=N)N
| StdInChI          = 1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)
| StdInChI_comment  = 
| StdInChIKey       = XZWYZXLIPXDOLR-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| density           = 
| melting_point     = 
| boiling_point     = 
| solubility        = 
| specific_rotation = 
| sec_combustion    = 
}}
<!-- Definition and medical uses -->
'''二甲双胍'''（{{lang-en|Metformin}}）{{notetag|{{標音|字=胍|注音=ㄍㄨㄚ |拼音=guā|同音字=瓜}}}}，常見商品名'''格华止'''、'''庫魯化'''（{{lang|en|Glucophage}}），為治疗[[2型糖尿病|2型糖尿病]]的[[療法|一线药物]]<ref name=AHFS2016/><ref name=Ann2016>{{cite journal|last1=Maruthur|first1=NM|last2=Tseng|first2=E|last3=Hutfless|first3=S|last4=Wilson|first4=LM|last5=Suarez-Cuervo|first5=C|last6=Berger|first6=Z|last7=Chu|first7=Y|last8=Iyoha|first8=E|last9=Segal|first9=JB|last10=Bolen|first10=S|title=Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis.|journal=Annals of Internal Medicine|date=19 April 2016|pmid=27088241|doi=10.7326/M15-2650}}</ref>，特别是针对[[超重|超重]]的患者<ref>{{cite book|title=Clinical Obesity.|date=2008|publisher=John Wiley & Sons|location=Oxford|isbn=9781405143660|page=262|edition=2nd|url=https://books.google.it/books?id=qGVnItPoPCYC&pg=PA262}}</ref>。本品也可用於治療[[多囊卵巢綜合症|多囊卵巢綜合症]]<ref name=AHFS2016/>，少數研究顯示也能用於預防糖尿病患者包含如[[心血管疾病|心血管疾病]]及[[癌症|癌症]]的併發症<ref>{{cite journal|last=Malek|first=M|author2=Aghili, R |author3=Emami, Z |author4= Khamseh, ME |title=Risk of Cancer in Diabetes: The Effect of Metformin.|journal=ISRN Endocrinology|date=2013|volume=2013|pages=636927|doi=10.1155/2013/636927|pmid=24224094|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800579/pdf/ISRN.ENDOCRINOLOGY2013-636927.pdf|format=PDF|pmc=3800579}}</ref><ref name=Pres2014>{{cite journal|title=Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.|journal=Prescrire international|date=November 2014|volume=23|issue=154|pages=269–72|pmid=25954799}}</ref>。本品屬於口服藥物<ref name=AHFS2016/>，且用藥不會造成體重增加<ref name=Pres2014/>。

<!-- Side effects and mechanism -->
二甲双胍在人體通常沒有顯著副作用<ref>{{cite journal|last1=Triggle|first1=CR|last2=Ding|first2=H|title=Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium.|journal=Acta physiologica (Oxford, England)|date=17 December 2015|pmid=26680745|doi=10.1111/apha.12644}}</ref>。常見副作用包含[[腹瀉|腹瀉]]、[[惡心|惡心]]，以及腹痛<ref name=AHFS2016/>，造成[[低血糖|低血糖]]的機會不大<ref name=AHFS2016/>。但值得關注的是，不當用藥可能會導致{{tsl|en|Lactic acidosis|乳酸中毒}}，嚴重者甚至會死亡<ref name="pmid21617112">{{cite journal |vauthors=Lipska KJ, Bailey CJ, Inzucchi SE | title = Use of metformin in the setting of mild-to-moderate renal insufficiency | journal = Diabetes Care | volume = 34 | issue = 6 | pages = 1431–7 |date=June 2011 | pmid = 21617112 | pmc = 3114336 | doi = 10.2337/dc10-2361 }}</ref>。肝病、[[腎功能衰竭|腎功能衰竭]]者不宜服用本品<ref name=AHFS2016/>，妊娠期間用藥目前沒有已知影響，但[[妊娠糖尿病|妊娠糖尿病]]一般建議以胰島素進行治療<ref name=AHFS2016/><ref>{{cite journal|last1=Lautatzis|first1=ME|last2=Goulis|first2=DG|last3=Vrontakis|first3=M|title=Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.|journal=Metabolism: clinical and experimental|date=November 2013|volume=62|issue=11|pages=1522–34|pmid=23886298|doi=10.1016/j.metabol.2013.06.006}}</ref>。本品屬於[[雙胍類|雙胍類]]藥物<ref name=AHFS2016>{{cite web|title=Metformin Hydrochloride|url=http://www.drugs.com/monograph/metformin-hydrochloride.html|publisher=The American Society of Health-System Pharmacists|accessdate=Jan 2016}}</ref>，藉由降低[[肝臟|肝臟]][[糖异生|糖質新生]]及提升胰島素敏感度來達到治療的效果<ref name=AHFS2016/>。

<!-- History, society, and culture -->
二甲双胍最早於1922年發現<ref name=Fis2010>{{cite book|last1=Fischer|first1=Janos|title=Analogue-based Drug Discovery II|date=2010|publisher=John Wiley & Sons|isbn=9783527632121|pages=47–49|url=https://books.google.co.jp/books?id=h2Kd8ci4Ln8C&pg=PA47}}</ref>，但直到1950年代，才由法國內科醫師讓·斯特恩（Jean Sterne）開啟了二甲双胍人类应用的临床研究<ref name=Fis2010/>。1957年，本品開始在法國用於藥用，並於1995年開始於美國使用<ref name=AHFS2016/><ref>{{cite book|last1=McKee|first1=Mitchell Bebel Stargrove, Jonathan Treasure, Dwight L.|title=Herb, nutrient, and drug interactions : clinical implications and therapeutic strategies|date=2008|publisher=Mosby/Elsevier|location=St. Louis, Mo.|isbn=9780323029643|page=217|url=https://books.google.co.jp/books?id=49kLK--eumEC&pg=PA217}}</ref>。本品列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref>{{cite web|title=WHO Model List of EssentialMedicines|url=http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|work=World Health Organization|accessdate=22 April 2014|date=October 2013}}</ref>。目前相信口服給藥是最有效的給藥途徑<ref name=Fis2010/>，本品屬於[[通用名藥物|通用名藥物]]<ref name=AHFS2016/>。2014年本品於[[已開發國家|已開發國家]]的批發價為0.21至5.55美金之間<ref>{{cite web|title=Metformin|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=ME500T&s_year=2014&year=2014&str=500%20mg&desc=Metformin%20HCl&pack=new&frm=TAB-CAP&rte=PO&class_code2=18%2E5%2E&supplement=&class_name=%2818%2E5%2E%29Insulins%20and%20medicines%20used%20for%20diabetes%3Cbr%3E|accessdate=11 January 2016}}{{dead link|date=2018年5月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>。在美國，一個月療程的藥物花費約於 5 至 25 美金之間<ref name=AHFS2016/>。

[[File:Metformin_500mg_Tablets.jpg|thumb]]

==药理==
作用于[[肝脏|肝脏]]，减少[[糖异生|糖异生]]（即葡萄糖的生产）与减轻[[胰岛素|胰岛素]]抵抗。<ref>{{cite web | url = http://www.onlineclinic.co.uk/metformin.html | publisher = OnlineClinic | title = How does this medication work? | accessdate = 2015-01-30}}</ref>

==优势==
不会增加体重

与其他药品相比不易造成低血糖

减少甘油三酯

对低密度脂蛋白有很好的效果

对血压无影响

价格较低

==缺点==
患中到重度肾脏疾病或心脏病者忌用，因为可能由于酗酒导致乳酸性中毒。

肠胃道症狀, 包括恶心、腹泻、腹痛

维生素B12缺乏

金属味觉

==抗衰老研究==
對二甲双胍在人類身上是否有抗[[衰老|衰老]]效果的臨床實驗預計於2016年冬在美國開始進行。<ref>{{Cite news |url=http://www.chinanews.com/gj/2015/12-02/7652205.shtml |title=世界首例抗衰老药将临床试验 或让人活到120岁 |publisher=中新網 |date=2015-12-02}}</ref>

== 註解 ==
{{NoteFoot}}

== 参考文献 ==
{{Reflist|30em}}

{{-}}
{{口服降糖药和胰岛素类似物}}

[[Category:胍|Category:胍]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:糖尿病药物|Category:糖尿病药物]]